The development and commercialization of a biologic, specifically a viral vector solution, requires rigorous quantitative and qualitative testing. Accurate determination of the physical titer of a viral vector pharmaceutical is critical to determine its clinical dosing. The presence of non-intact particles or particles that did not package any genome are undesirable as these can cause unnecessary immunogenicity. Determining the physical titer and the ratio of empty to fully packaged capsids is important for development and monitoring of viral vector preparations.
We are the global leader in applying the “negative staining polystyrene bead protocol”
(Monroe and Brandt, 1970, PMID: 4098102) to estimate the concentration of particles in a sample. We mix the sample with a known concentration of polystyrene beads and acquire a large dataset of images using negative stain TEM to ensure appropriate particle counts.
A senior analyst manually identifies and scores particles and polystyrene beads until the required total number of particles has been counted. The ratio of particles vs. polystyrene beads of known concentration is then converted to an estimate of the number of particles/ml. This service can be used only on negative stain images.
Samples We've Characterized
- Virus-Like Particles (VLPs)
- Associated Adeno-Virus (AAV) Characterization
- Hepatitis B Virus (HBV ) Characterization
- Human Papillomavirus (HPV) Characterization
- Lentivirus Characterization